| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 190.35× | 190.35× | 106.41× | 113.80× | 139.22× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 7.98× | 8.63× | 3.20× | 5.36× | 3.67× | ||
| 0.64× | 0.64× | 1.19× | 1.27× | 1.25× | ||
| −2.07× | −2.07× | −2.21× | 3.64× | 10.03× | ||
| −2.61× | −2.61× | −1.05× | 1.44× | 0.80× |
From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/06/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 139.22 | 113.80 | 106.41 | 190.35 | 190.35 | |
| Working Capital Turnover | 3.67 | 5.36 | 3.20 | 8.63 | 7.98 | |
| Asset Turnover | 1.25 | 1.27 | 1.19 | 0.64 | 0.64 | |
| Cash Conversion (CFO/Net Income) | 10.03 | 3.64 | -2.21 | -2.07 | -2.07 | |
| CFO/EBITDA | 0.80 | 1.44 | -1.05 | -2.61 | -2.61 |